UMIN-CTR Clinical Trial

Basic information
Official scientific title of the study	Analysis of expression of CD44 and podocalyxin in head and neck cancer
Title of the study (Brief title)	Analysis of expression of CD44 and podocalyxin in head and neck cancer
Region	Japan

Condition
Condition	head and neck cancer
Classification by specialty	Oto-rhino-laryngology
Classification by malignancy	Malignancy
Genomic information	NO

Objectives
Narrative objectives1	Analysis of expression of CD44 and podocalyxin in head and neck cancer
Basic objectives2	Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Expression of CD44 and podocalyxin in head and neck cancer
Key secondary outcomes

Base
Study type	Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	Not applicable
Age-upper limit	Not applicable
Gender	Male and Female
Key inclusion criteria	Head and neck cancer
Key exclusion criteria	patient who reject joining in this trial
Target sample size	50

Research contact person
Name of lead principal investigator	Eiji Yumoto
Organization	Kumamoto University Graduate School of Medicine
Division name	Department of Otolaryngology-Head and Neck Surgery
Address	1-1-1 Honjo, Kumamoto 860-8556, Japan
TEL	096-373-5255
Email	jibika-ikyoku@fc.kuh.kumamoto-u.ac.jp

Public contact
Name of contact person	Daizo Murakami
Organization	Kumamoto University Graduate School of Medicine
Division name	Department of Otolaryngology-Head and Neck Surgery
Address	1-1-1 Honjo, Kumamoto 860-8556, Japan
TEL	096-373-5255
Homepage URL
Email	daizo-m@fc.kuh.kumamoto-u.ac.jp

Sponsor
Institute	Kumamoto University Graduate School of Medicine
Institute
Department

Funding Source
Organization	Grants-in-Aid for Scientific Research
Organization
Division
Category of Funding Organization	Other
Nationality of Funding Organization	Japan

Other related organizations
Co-sponsor
Name of secondary funｄer(s)

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions	熊本大学医学部付属病院

Other administrative information
Date of disclosure of the study information	2015 Year 06 Month 01 Day

Progress
Recruitment status	Open public recruiting
Date of protocol fixation	2012 Year 07 Month 01 Day
Anticipated trial start date	2012 Year 07 Month 01 Day
Last follow-up date	2016 Year 03 Month 31 Day
Date of closure to data entry	2016 Year 03 Month 31 Day
Date trial data considered complete	2016 Year 03 Month 31 Day
Date analysis concluded	2016 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results	Unpublished
URL releasing results
Results
Other related information	There is no expression op podocalyxin in squamous cell carcinoma of head and Neck. So, this study was finished.

Management information
Registered date	2015 Year 05 Month 30 Day
Last modified on	2018 Year 10 Month 14 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020554